103 related articles for article (PubMed ID: 24737201)
1. Overexpression of fibulin-4 is associated with tumor progression and poor prognosis in patients with cervical carcinoma.
Chen J; Zhang J; Liu X; Fang R; Zhao Y; Ma D
Oncol Rep; 2014 Jun; 31(6):2601-10. PubMed ID: 24737201
[TBL] [Abstract][Full Text] [Related]
2. Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas.
Chen J; Liu Z; Fang S; Fang R; Liu X; Zhao Y; Li X; Huang L; Zhang J
BMC Cancer; 2015 Mar; 15():91. PubMed ID: 25885889
[TBL] [Abstract][Full Text] [Related]
3. Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo.
Li J; Qi C; Liu X; Li C; Chen J; Shi M
Sci Rep; 2018 Jul; 8(1):10594. PubMed ID: 30006571
[TBL] [Abstract][Full Text] [Related]
4. Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway.
Zhang D; Wang S; Chen J; Liu H; Lu J; Jiang H; Huang A; Chen Y
Int J Oncol; 2017 May; 50(5):1513-1530. PubMed ID: 28339091
[TBL] [Abstract][Full Text] [Related]
5. Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
Wang T; Wang M; Fang S; Wang Q; Fang R; Chen J
Oncotarget; 2017 Mar; 8(12):18991-19012. PubMed ID: 28177909
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of EFEMP1 correlates with tumor progression and poor prognosis in human ovarian carcinoma.
Chen J; Wei D; Zhao Y; Liu X; Zhang J
PLoS One; 2013; 8(11):e78783. PubMed ID: 24236050
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
8. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
Meng F; Tan S; Liu T; Song H; Lou G
Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
Cao W; Peng T; Zhou Y
J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
[TBL] [Abstract][Full Text] [Related]
10. GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
Ouyang F; Liu J; Xia M; Lin C; Wu X; Ye L; Song L; Li J; Wang J; Guo P; He M
Oncol Rep; 2017 May; 37(5):2652-2662. PubMed ID: 28405687
[TBL] [Abstract][Full Text] [Related]
11. The expression of EFEMP1 in cervical carcinoma and its relationship with prognosis.
En-lin S; Sheng-guo C; Hua-qiao W
Gynecol Oncol; 2010 Jun; 117(3):417-22. PubMed ID: 20378157
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer.
Liu P; Xin F; Ma CF
Genet Mol Res; 2015 Dec; 14(4):17995-8002. PubMed ID: 26782446
[TBL] [Abstract][Full Text] [Related]
13. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
14. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
15. Decreased preoperative serum fibulin-3 levels in colon cancer patients.
Simsek O; Kocael A; Kemik A; Vatankulu B; Kocael P; Halac M; Ulualp K; Sonmezoglu K
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4076-80. PubMed ID: 26592829
[TBL] [Abstract][Full Text] [Related]
16. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
[TBL] [Abstract][Full Text] [Related]
17. Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer.
Zhou X; Xu CJ; Wang JX; Dai T; Ye YP; Cui YM; Liao WT; Wu XL; Ou JP
Int J Gynecol Cancer; 2015 Oct; 25(8):1353-63. PubMed ID: 26332389
[TBL] [Abstract][Full Text] [Related]
18. p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis.
Jiang C; Xu R; Li XX; Wang YY; Liang WQ; Zeng JD; Zhang SS; Xu XY; Yang Y; Zhang MY; Wang HY; Zheng XFS
Cell Cycle; 2017 Sep; 16(18):1673-1682. PubMed ID: 28841361
[TBL] [Abstract][Full Text] [Related]
19. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SPARC correlates with poor prognosis in patients with cervical carcinoma and regulates cancer cell epithelial-mesenchymal transition.
Shi D; Jiang K; Fu Y; Fang R; Liu XI; Chen J
Oncol Lett; 2016 May; 11(5):3251-3258. PubMed ID: 27123099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
